510(k) Report

FDA product code · General and plastic surgery

Non-Absorbable, Expandable, Hemostatic Sponge For Temporary Internal Use

PGZClass II21 CFR 878.4452510(k) required7 decisions since 20140 recalls

7 FDA decisions since 2014. 510(k) reviews decided 2021–2025 took a median of 110 days (half between 77 and 142). No recall names this code. The most-cited predicate is K152624, named by 2 later devices.

To control bleeding in junctional, non-compressible wounds until surgical care is acquired.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, general and plastic surgery panel

Twenty years of PGZ at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · PGZ

1in 2025

2014: 12015: 12016: 12017: 12018: 12021: 12025: 1
2007high 1 (2014) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PGZ

Too few PGZ 510(k)s in any year since 2007 to give a median.

Recalls per year · PGZ

No recall names PGZ since 2007.

Adverse event reports per year · PGZ

No MAUDE report names PGZ since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20141—00
20151—00
20161—00
20171—00
20181—00
20190—00
20200—00
20211—00
20220—00
20230—00
20240—00
20251—00
20260—0—
FIG. 1 — PGZ by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in PGZ? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report